| HOME >> MEDICINE >> TECHNOLOGY |
Provisions Regarding Off-Label Usage of Contrast Media 116
Contrast Media 116
X-ray Contrast Media 116
MRI Contrast Media 116
Market Scenario 116
Managed Care Vs MRI Technology Diffusion 117
Ultrasound Contrast Media 117
B.Market Analytics 117
Table 27: US Recent Past, Current & Future Analysis for
Imaging Agents by Product Segment - Contrast Media (X-ray,
MRI and Ultrasound) and Diagnostic Radiopharmaceuticals
Markets Independently Analyzed with Annual Sales in US$
Million for Years 2007 through 2015 (includes corresponding
Graph/Chart) 117
Table 28: US Historic Review for Imaging Agents by Product
Segment - Contrast Media (X-ray, MRI and Ultrasound) and
Diagnostic Radiopharmaceuticals Independently Analyzed with
Annual Sales Figures in US$ Million for Years 2000 through
2006 (includes corresponding Graph/Chart) 118
Table 29: US 11-Year Perspective for Imaging Agents by
Product Segment - Percentage Breakdown of Dollar Sales for
Contrast Media (X-ray, MRI and Ultrasound) and Diagnostic
Radiopharmaceuticals Markets for Years 2005, 2010 & 2015
(includes corresponding Graph/Chart) 119
16. CANADA 120
A.Market Analysis 120
Outlook 120
Diagnostic Equipment Market 120
LOCM Products Approved in Canada 120
B.Market Analytics 121
Table 30: Canadian Recent Past, Current & Future Analysis
for Imaging Agents by Product Segment- Contrast Media
(X-ray, MRI and Ultrasound) and Diagnostic
Radiopharmaceuticals Markets Independently Analyzed with
Annual Sales in US$ Million for Years 2007 through 2015
(includes corresponding Graph/Chart) 121
Table 31: Canadian Historic Review for Imaging Agents by
Product Segment - Contrast Media (X-ray, MRI and Ultrasound)
and Diagnostic Radiopharmaceuticals Independently
'/>"/>
| SOURCE Reportlinker Copyright©2010 PR Newswire. All rights reserved |